Performance of 2019 EULAR/ACR classification criteria for systemic lupus erythematosus in a paediatric population-a multicentre study.


Journal

Rheumatology (Oxford, England)
ISSN: 1462-0332
Titre abrégé: Rheumatology (Oxford)
Pays: England
ID NLM: 100883501

Informations de publication

Date de publication:
03 11 2021
Historique:
received: 12 11 2020
revised: 18 01 2021
pubmed: 10 2 2021
medline: 29 12 2021
entrez: 9 2 2021
Statut: ppublish

Résumé

The European League Against Rheumatism and American College of Rheumatology 2019 (EULAR/ACR-19) criteria for the diagnosis of SLE were recently published, with the stated goal of maintaining the level of sensitivity and raising the level of specificity for classification of SLE in adults. The aim of this study is to examine their application to juvenile SLE (jSLE) patients. In this multicentre study the charts of jSLE patients from three tertiary medical centres were reviewed and compared with patients with non-jSLE diagnosis. Paediatric rheumatologists, blinded to the original diagnosis, reviewed and diagnosed all cases. Paediatric patients' clinical and laboratory data were retrospectively extracted and then examined with regard to how they met the new and old criteria. Included were 225 patients (112 jSLE, 113 non-SLE). When applied to juvenile SLE classification, the sensitivity of the new EULAR/ACR-19 criteria was 0.96 (95% CI: 0.9, 0.99) and the specificity was 0.89 (95% CI: 0.82, 0.94). These were comparable to the SLICC criteria. The sensitivity of the EULAR/ACR-19 criteria improves over time and was 0.83 12 months following disease onset, reaching 0.96 after longer than 24 months. Among a cohort of jSLE patients, sensitivity of the new EULAR/ACR-19 criteria was found to be high and specificity may have improved slightly compared with the SLICC-12 criteria. We support the use of the new classification criteria for paediatric patients in future jSLE studies, but it should be noted that its specificity is lower than for adults.

Identifiants

pubmed: 33560345
pii: 6131692
doi: 10.1093/rheumatology/keab140
doi:

Types de publication

Comparative Study Journal Article Multicenter Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

5142-5148

Informations de copyright

© The Author(s) 2021. Published by Oxford University Press on behalf of the British Society for Rheumatology. All rights reserved. For permissions, please email: journals.permissions@oup.com.

Auteurs

Yoel Levinsky (Y)

Department of Pediatrics B, Schneider Children's Medical Center of Israel, Petach Tikva.
Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv.

Mor Broide (M)

Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv.
Department of Pediatrics A, Schneider Children's Medical Center.

Shelly Kagan (S)

Department of Pediatrics B, Schneider Children's Medical Center of Israel, Petach Tikva.
Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv.

Ori Goldberg (O)

Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv.
Pediatric Pulmonary Unit.

Oded Scheuerman (O)

Department of Pediatrics B, Schneider Children's Medical Center of Israel, Petach Tikva.
Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv.

Rotem Tal (R)

Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv.
Pediatric Rheumatology Unit, Schneider Children's Medical Center of Israel, Petach Tikva.

Irit Tirosh (I)

Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv.
Pediatric Rheumatology Service, Edmond and Lily Safra Children's Hospital, Sheba Medical Center, Tel Hashomer.

Yoni Butbul (Y)

Pediatric Rheumatology Service, Ruth Rappaport Children's Hospital, Rambam Health Care Campus.
The Ruth and Bruce Rappaport Faculty of Medicine, Technion-Israel Institute of Technology, Haifa, Israel.

Daniel E Furst (DE)

Department of Medicine, Rheumatology Division, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA.
Department of Experimental and Clinical Medicine, University of Florence, and Division of Rheumatology AOUC, Florence, Italy and.
Department of Rheumatology, University of Washington, Seattle, WA, United States.

Liora Harel (L)

Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv.
Pediatric Rheumatology Unit, Schneider Children's Medical Center of Israel, Petach Tikva.

Gil Amarilyo (G)

Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv.
Pediatric Rheumatology Unit, Schneider Children's Medical Center of Israel, Petach Tikva.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH